AlphaFold predicted structure
PYCR2 · Q96C36

Mean pLDDT
89.6/ 100
Confident
320 residues
Confidence breakdown
- Very high(≥ 90)83%
- Confident(70–90)2%
- Low(50–70)6%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
pyrroline-5-carboxylate reductase 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalInherited white matter disorders
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalhypomyelinating leukodystrophy 10
Hypomyelinating leukodystrophy with or without oligondontia and/or hypogonadism
leukodystrophy
autosomal recessive primary microcephaly
Intellectual disability
hereditary disease
metachromatic leukodystrophy
neurodegenerative disease
microcephaly
colorectal carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Pyrroline-5-carboxylate reductase 2
Oxidoreductase that catalyzes the last step in proline biosynthesis, which corresponds to the reduction of pyrroline-5-carboxylate to L-proline using NAD(P)H (PubMed:23024808, PubMed:2722838, PubMed:6894153). At physiologic concentrations, has higher specific activity in the presence of NADH (PubMed:23024808, PubMed:2722838, PubMed:6894153). Involved in cellular response to oxidative stress (PubMed:25865492). In some cell types, such as erythrocytes, its primary function may be the generation of NADP(+) (PubMed:2722838, PubMed:6894153)
PYCR2 · Q96C36

Mean pLDDT
89.6/ 100
Confident
320 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0